| Photodynamic therapy for superficial basal cell carcinoma and Bowen's disease. | |
| | |
MedLine Citation:
|
PMID: 16436340 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Photodynamic therapy (PDT) is an effective treatment for superficial basal cell carcinoma (BCCs) and Bowen's disease. Several studies have reported complete response rates of 80-95% and an excellent cosmetic outcome. Bowen's disease and superficial basal cell carcinomas characteristically affect older patients who may also have associated difficulties with mobility. Using a portable PDT light source we were able to deliver PDT in a community setting with the aim of providing a more convenient service for patients. This randomised study confirmed that community delivered PDT is a viable treatment option and can be administered safely in the community by a trained dermatology nurse. The results from patient questionnaires suggest that community delivered PDT is more convenient to the patient, and also cost effective. |
| | |
Authors:
|
T H Clayton; J Tait; C Whitehurst; V M Yates |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: European journal of dermatology : EJD Volume: 16 ISSN: 1167-1122 ISO Abbreviation: Eur J Dermatol Publication Date: 2006 Jan-Feb |
Date Detail:
|
Created Date: 2006-01-26 Completed Date: 2006-05-26 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9206420 Medline TA: Eur J Dermatol Country: France |
Other Details:
|
Languages: eng Pagination: 39-41 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Lancaster Royal Infirmary, UK. Tim.Clayton@leedsth.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Biopsy, Needle Bowen's Disease / drug therapy*, mortality, pathology Carcinoma, Basal Cell / drug therapy*, mortality, pathology Female Great Britain / epidemiology Humans Immunohistochemistry Male Middle Aged Neoplasm Staging Photochemotherapy / methods* Prognosis Prospective Studies Risk Assessment Skin Neoplasms / drug therapy*, mortality, pathology Survival Rate Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Study on the expression of RXRalpha in patients with psoriasis vulgaris.
Next Document: Usefulness of itraconazole for sporotrichosis in Japan: study of three cases and literature comparis...